跳转至内容
Merck
CN
所有图片(1)

主要文件

J4455

Sigma-Aldrich

JSH-23

≥98% (HPLC), solid

别名:

4-甲基-N1-(3-苯基丙基)-1,2-苯二胺

登录查看公司和协议定价

选择尺寸

10 MG
¥2,277.32
50 MG
¥6,550.73

¥2,277.32


有货详情


获取大包装报价

选择尺寸

变更视图
10 MG
¥2,277.32
50 MG
¥6,550.73

About This Item

经验公式(希尔记法):
C16H20N2
CAS Number:
分子量:
240.34
UNSPSC代码:
51111800
NACRES:
NA.77

¥2,277.32


有货详情


获取大包装报价

质量水平

方案

≥98% (HPLC)

表单

solid

储存条件

protect from light

颜色

off-white to gray-pink

溶解性

DMSO: >10 mg/mL

运输

wet ice

储存温度

−20°C

SMILES字符串

N(CCCc2ccccc2)c1c(cc(cc1)C)N

InChI

1S/C16H20N2/c1-13-9-10-16(15(17)12-13)18-11-5-8-14-6-3-2-4-7-14/h2-4,6-7,9-10,12,18H,5,8,11,17H2,1H3

比较类似商品

查看完整比较结果

显示差异

1 of 4

此商品
SML1915F8807S8076
曲尼司特 ≥98% (HPLC), powder

T0318

曲尼司特

T-26c ≥98% (HPLC)

SML1915

T-26c

FM19G11 ≥98% (HPLC)

F8807

FM19G11

SJ000025081 ≥98% (HPLC)

S8076

SJ000025081

form

powder

form

powder

form

powder

form

powder

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

-

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

solubility

DMSO: >10 mg/mL, H2O: insoluble

solubility

DMSO: 10 mg/mL, clear

solubility

DMSO: ≥40 mg/mL

solubility

DMSO: ≥40 mg/mL

originator

Kissei

originator

-

originator

-

originator

-

应用

JSH-23 已被用作一种核因子 κB(NF-κB)p65 抑制剂。[1][2][3]

生化/生理作用

JSH-23 是一种 NF-κB 核易位抑制剂。
JSH-23 是一种 NF-κB 核易位抑制剂。EMSA 和蛋白质印迹分析表明,它抑制 LPS 和细胞因子诱导的 NF-kB p65 亚基的核易位过程。该化合物具有适度的抑制活性(RAW 264.7 细胞中 IC50 值为 7.1 uM),但不影响 IkB 降解或恢复。该化合物以剂量依赖性方式抑制 LPS 诱导的细胞因子、COX2 和 iNOS 的表达,并且可能结合或干扰 p65 的和定位信号(NLS)。

其他说明

光和空气敏感。

储存分类代码

11 - Combustible Solids

WGK

WGK 3


  • 历史批次信息供参考:

    分析证书(COA)

    Lot/Batch Number

    没有发现合适的版本?

    如果您需要特殊版本,可通过批号或批次号查找具体证书。

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    Junfeng Zhu et al.
    Journal of pharmaceutical and biomedical analysis, 134, 100-107 (2016-11-28)
    Danhong injection (DHI) is a widely used Chinese medicine injection (CMI) for the clinical treatment of cardiovascular and cerebrovascular diseases. In this study, a simple and efficient in vitro method based on ultrafiltration LC-MS and molecular modeling has been developed
    Wireeya Chawjiraphan et al.
    MethodsX, 7, 101114-101114 (2020-11-17)
    A simple and sensitive graphene oxide-mediated fluorescence quenching aptasensor is developed to quantify albuminuria in urine samples. The developed aptasensor used the specific target binding property of aptamer and fluorescence quenching property of graphene oxide to determine the concentration of
    Yongjia Fan et al.
    ACS biomaterials science & engineering, 3(8), 1510-1518 (2016-08-14)
    The development of platforms for the expansion and directed differentiation of human pluripotent stem cells (hPSCs) in large quantities under xeno-free conditions is a key step toward the realization of envisioned stem cell-based therapies. Microcarrier bioreactors afford great surface-to-volume ratio
    Yasuhiro Kawai et al.
    PloS one, 13(5), e0196655-e0196655 (2018-05-26)
    Serum albumin is the major intravascular antioxidant. Though oxidative stress plays an important role in the pathophysiology of Immunoglobulin A nephropathy (IgAN), the association between serum albumin and the progression of IgAN is not entirely understood. This retrospective cohort study
    D Moreno et al.
    Theriogenology, 84(7), 1053-1060 (2015-08-19)
    The aim of this study was to develop an in vitro embryo culture medium without either fetal calf serum or BSA, using various growth factors and cytokines (GFs-CYKs; IGF-I, IGF-II, bFGF, LIF, GM-CSF, TGF-β1, and PDGF-BB), and other molecules with

    商品

    Discover Bioactive Small Molecules for Lipid Signaling Research

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系客户支持